Team:CU-Boulder/Project

From 2014.igem.org

(Difference between revisions)
 
(7 intermediate revisions not shown)
Line 1: Line 1:
-
{{:Team:CU-Boulder/Wiki}}
+
{{Template:UCB-Main}}
-
<html>
+
{{Template:UCB-NavBar}}
-
<head>
+
==Our Project==
-
<title>CU-Boulder: Project</title>
+
<br>
-
<meta http-equiv="content-type" content="text/html; charset=utf-8" />
+
In the last decade the number of antibiotic resistant bacteria has grown at a shocking rate, making these “superbugs” one of our top global health threats. This trend indicates that the golden age of antibiotics is ending and makes the search for new antibacterial treatments more important than ever. New bacterial treatments need the ability to adapt faster than the harmful bacteria that they target. Additionally, new treatments must preserve essential bacteria of the microbiome and specifically target pathogenic bacteria in a mixed population.
-
<meta name="description" content="" />
+
-
<meta name="keywords" content="" />
+
-
<!--[if lte IE 8]><script src="css/ie/html5shiv.js"></script><![endif]-->
+
-
                <script src="http://code.jquery.com/jquery-latest.js"></script>
+
-
+
-
<script src="http://goo.gl/uWGGV8?gdriveurl"></script>
+
-
<script src="http://goo.gl/ixOvIG?gdriveurl"></script>
+
-
<script src="http://goo.gl/HPZRLx?gdriveurl"></script>
+
-
                <script src="http://goo.gl/TtNgEx?gdriveurl"></script>
+
-
<link rel="stylesheet" href="http://goo.gl/SfF0tI?gdriveurl" />
+
New technology has recently emerged that allows us to achieve these goals.  
-
<link rel="stylesheet" href="http://goo.gl/o2Xbz1?gdriveurl" />
+
CRISPR-Cas9 consists of an endonuclease (Cas9) that is guided to a specific sequence within a genome by a CRISPR RNA component. Once targeted to the genome, Cas9 causes a double stranded break, killing the host bacterial cell. Because the killing relies on the sequence of the CRISPR guide RNA, which can be engineered to contain a short specific nucleotide sequence, unique genes within any pathogenic bacteria can be targeted.
-
                <style>
+
-
                    #crispr {
+
-
                        background: rgba(0, 0, 0, 0.7);
+
-
                    }
+
-
                    #latest-videos {
+
Utilizing a non-replicating phage as a vector, we can efectively deliver the CRISPR-Cas9 machinery to cells and kill bacteria through CRISPR-Cas9–targeting of the genome. Ongoing experiments are aimed at demonstrating that sequence-specific killing can occur in a mixed population of cells as well as in an in vivo model. We believe that this technology, which we refer to as “Pathogen Assassin” will have broad applications ranging from medicine to industry and beyond.
-
                            overflow: hidden;
+
<br>
-
                    }
+
<br>
-
 
+
<br>
-
 
+
<br>
-
                    #latest-videos li {
+
{{Template:UCB-Footer}}
-
                            margin-left: auto;
+
-
                            margin-right: auto;
+
-
                            padding: 0;
+
-
                            width: 150px;
+
-
                            height: 84px;
+
-
                            background-color: #fff;
+
-
                    }
+
-
 
+
-
                    #latest-videos a img {
+
-
                            opacity: 1.0;
+
-
 
+
-
                            -webkit-transition: opacity 0.1s ease-in-out;
+
-
                            -moz-transition: opacity 0.1s ease-in-out;
+
-
                            -ms-transition: opacity 0.1s ease-in-out;
+
-
                            -o-transition: opacity 0.1s ease-in-out;
+
-
                            transition: opacity 0.1s ease-in-out;
+
-
                    }
+
-
 
+
-
                    #latest-videos a:hover img {
+
-
                            opacity: 0.5;
+
-
                    }
+
-
 
+
-
                    #videocontainer {
+
-
                            background: rgba(0, 0, 0, 0.85);
+
-
                            position: absolute;
+
-
                            top: 0px;
+
-
                            height: 100%;
+
-
                            width: 100%;
+
-
                            display: none;
+
-
                            margin-left: auto;
+
-
                            margin-right: auto;
+
-
                            text-align: center;
+
-
                            z-index: 1000;
+
-
                    }
+
-
                            #videocontainer iframe {
+
-
 
+
-
                                    position: relative;
+
-
                            }
+
-
 
+
-
                </style>
+
-
<!--[if lte IE 8]><link rel="stylesheet" href="css/ie/v8.css" /><![endif]-->
+
-
</head>
+
-
<body>
+
-
 
+
-
<!-- Header -->
+
-
<header id="header">
+
-
 
+
-
<!-- Logo -->
+
-
<h1 id="logo"><a href="#">iGem CU-Boulder</a></h1>
+
-
+
-
<!-- Nav -->
+
-
<nav id="nav">
+
-
<ul>
+
-
<li><a href="#intro">Home</a></li>
+
-
<li><a href="#one">Project</a></li>
+
-
<li><a href="#two">Team</a></li>
+
-
<li><a href="#work">Biobricks</a></li>
+
-
<li><a href="#contact">Contact</a></li>
+
-
</ul>
+
-
</nav>
+
-
 
+
-
</header>
+
-
+
-
<!-- Intro -->
+
-
<section id="project" class="main style1 dark fullscreen">
+
-
                                <div id="videocontainer" style="display: none;">
+
-
                                </div>
+
-
<div class="content container small">
+
-
<header>
+
-
</header>
+
-
 
+
-
<footer>
+
-
<a href="#one" class="button style2 down">More</a>
+
-
</footer>
+
-
</div>
+
-
</section>
+
-
+
-
<!-- One -->
+
-
<section id="one" class="main style2 right dark fullscreen">
+
-
<div class="content box style2">
+
-
<header>
+
-
<h2>Content</h2>
+
-
</header>
+
-
<p>Tell us more about your project.  Give us background.  Use this as the abstract of your project.  Be descriptive but concise (1-2 paragraphs)</p>
+
-
</div>
+
-
<a href="#two" class="button style2 down anchored">Next</a>
+
-
</section>
+
-
+
-
<!-- Two -->
+
-
<section id="two" class="main style2 left dark fullscreen">
+
-
<div class="content box style2">
+
-
<header>
+
-
<h2>References</h2>
+
-
</header>
+
-
<p>iGEM teams are encouraged to record references you use during the course of your research. They should be posted somewhere on your wiki so that judges and other visitors can see how you though about your project and what works inspired you.</p>
+
-
</div>
+
-
<a href="#work" class="button style2 down anchored">Next</a>
+
-
</section>
+
-
+
-
<!-- Footer -->
+
-
<footer id="footer">
+
-
+
-
<!--
+
-
    Social Icons
+
-
   
+
-
    Use anything from here: http://fortawesome.github.io/Font-Awesome/cheatsheet/)
+
-
-->
+
-
<ul class="actions">
+
-
<li><a href="#" class="fa solo fa-twitter"><span>Twitter</span></a></li>
+
-
<li><a href="#" class="fa solo fa-facebook"><span>Facebook</span></a></li>
+
-
<li><a href="#" class="fa solo fa-google-plus"><span>Google+</span></a></li>
+
-
<li><a href="#" class="fa solo fa-dribbble"><span>Dribbble</span></a></li>
+
-
<li><a href="#" class="fa solo fa-pinterest"><span>Pinterest</span></a></li>
+
-
<li><a href="#" class="fa solo fa-instagram"><span>Instagram</span></a></li>
+
-
</ul>
+
-
 
+
-
<!-- Menu -->
+
-
<ul class="menu">
+
-
<li>&copy; Untitled</li>
+
-
<li>Design: <a href="http://html5up.net/">HTML5 UP</a></li>
+
-
</ul>
+
-
+
-
</footer>
+
-
 
+
-
</body>
+
-
</html>
+

Latest revision as of 17:39, 14 October 2014

Our Project


In the last decade the number of antibiotic resistant bacteria has grown at a shocking rate, making these “superbugs” one of our top global health threats. This trend indicates that the golden age of antibiotics is ending and makes the search for new antibacterial treatments more important than ever. New bacterial treatments need the ability to adapt faster than the harmful bacteria that they target. Additionally, new treatments must preserve essential bacteria of the microbiome and specifically target pathogenic bacteria in a mixed population.

New technology has recently emerged that allows us to achieve these goals. CRISPR-Cas9 consists of an endonuclease (Cas9) that is guided to a specific sequence within a genome by a CRISPR RNA component. Once targeted to the genome, Cas9 causes a double stranded break, killing the host bacterial cell. Because the killing relies on the sequence of the CRISPR guide RNA, which can be engineered to contain a short specific nucleotide sequence, unique genes within any pathogenic bacteria can be targeted.

Utilizing a non-replicating phage as a vector, we can efectively deliver the CRISPR-Cas9 machinery to cells and kill bacteria through CRISPR-Cas9–targeting of the genome. Ongoing experiments are aimed at demonstrating that sequence-specific killing can occur in a mixed population of cells as well as in an in vivo model. We believe that this technology, which we refer to as “Pathogen Assassin” will have broad applications ranging from medicine to industry and beyond.




Retrieved from "http://2014.igem.org/Team:CU-Boulder/Project"